The first PSYCH Investor Summit: Europe & Asia is a concise programme of networking, pitches and insights.

This global psychedelics industry event will showcase expanding businesses looking for capital – delivering the industry’s most promising opportunities directly to investors & funds. 

The global psychedelics industry is expected to be worth over US$100 billion with the potential to save $1 trillion on lost productivity - disrupting the way the world will approach healthcare. 

PSYCH helps investors, operators and regulators navigate the many opportunities through data, intelligence and networking. 

Engage with distinguished industry leaders, rising entrepreneurs and global psychedelics investors to share insights and help develop this emerging frontier.